2019 Outlook: Find a New Balance between Survival and Development of China's Biopharmaceutical Industry

2018 witnessed the rational development of China's biopharmaceutical industry. In 2019, with the changes in political and economic environment, biopharmaceutical enterprises will enter a new period of adjustment. At the beginning of 2019, Shanghai Center for Innovation Drug Discovery and Development (SCIDDD) held a series of roundtable brainstorming, and proposed the 2019 outlook of China's biopharmaceutical industry, emphasizing that biopharmaceutical enterprises need to find a new balance between survival and development.